Vericel Corp. (VCEL)
39.89
-1.06
(-2.59%)
USD |
NASDAQ |
Aug 31, 16:00
39.89
0.00 (0.00%)
After-Hours: 20:00
Vericel Cash and Short Term Investments (Quarterly) : 162.46M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 162.46M |
| March 31, 2026 | 145.34M |
| December 31, 2025 | 137.50M |
| September 30, 2025 | 135.38M |
| June 30, 2025 | 116.88M |
| March 31, 2025 | 119.12M |
| December 31, 2024 | 126.74M |
| September 30, 2024 | 118.40M |
| June 30, 2024 | 128.07M |
| March 31, 2024 | 118.45M |
| December 31, 2023 | 127.34M |
| September 30, 2023 | 128.43M |
| June 30, 2023 | 125.62M |
| March 31, 2023 | 119.28M |
| December 31, 2022 | 119.54M |
| September 30, 2022 | 110.94M |
| June 30, 2022 | 100.69M |
| March 31, 2022 | 100.55M |
| December 31, 2021 | 103.40M |
| September 30, 2021 | 98.29M |
| June 30, 2021 | 90.98M |
| March 31, 2021 | 83.56M |
| December 31, 2020 | 75.81M |
| September 30, 2020 | 85.54M |
| June 30, 2020 | 80.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 81.58M |
| December 31, 2019 | 69.72M |
| September 30, 2019 | 74.66M |
| June 30, 2019 | 66.01M |
| March 31, 2019 | 84.08M |
| December 31, 2018 | 82.92M |
| September 30, 2018 | 97.75M |
| June 30, 2018 | 94.97M |
| March 31, 2018 | 29.78M |
| December 31, 2017 | 26.86M |
| September 30, 2017 | 15.47M |
| June 30, 2017 | 14.04M |
| March 31, 2017 | 19.85M |
| December 31, 2016 | 22.98M |
| September 30, 2016 | 8.88M |
| June 30, 2016 | 9.835M |
| March 31, 2016 | 13.54M |
| December 31, 2015 | 14.58M |
| September 30, 2015 | 18.72M |
| June 30, 2015 | 20.22M |
| March 31, 2015 | 25.90M |
| December 31, 2014 | 30.34M |
| September 30, 2014 | 37.58M |
| June 30, 2014 | 7.263M |
| March 31, 2014 | 8.836M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie, Inc. | 6.569B |
| ADMA Biologics, Inc. | 136.02M |
| Kyntra Bio, Inc. | 91.32M |
| Conexeu Sciences, Inc. | 7.302M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |